Clinical Trial Update: Brain Insulin Resistance in Mood Disorders [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on intranasal insulin targeting brain insulin resistance in mood disorders, spanning Phase 1 and Phase 2 for major depressive disorder and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Major Depressive Disorder, Bipolar Disorder | Phase 1, Phase 2 | Status: UNKNOWN